Sheri Tarr of 68 Partners explains why packaging, marketing claims, and sales messaging deserve as much compliance attention as testing and manufacturing.
Wine, packaged goods and tobacco have spent decades studying consumer behavior. Here’s how cannabis operators can take a deeper look at why customers buy, whether they return to the same products and how their purchasing habits change over time.
Clear procedures help employees catch inventory errors early, maintain accurate records, and prevent small mistakes from causing bigger problems later in production.
How CO₂ distribution, humidity control and environmental monitoring influence crop performance, operating costs and worker safety.
CEO Micah Anderson discusses the economics of cannabis cultivation, lessons from New York, and preparing for interstate and international commerce.
Purchase history tells dispensaries what customers buy, but understanding how products work for them may be the key to earning repeat business.
Nearly 145,000 lab samples reveal how far regulated cannabis flower is falling below the ASTM water activity standard.
How state regulators plan to root out THC inflation and bring accountability to compliance testing.
On one side is the DEA, where the administrative law judge must issue his recommendation. On the other hand, Congress is deciding whether to delay, revise, or replace the hemp restrictions scheduled to take effect later this year.
Medical cannabis companies can look to pharmaceutical packaging standards for guidance on child resistance, tamper evidence and track-and-trace.
